NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

CUSIP: 641288105

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
33,235,472
Total 13F shares
18,073,997
Share change
+560,498
Total reported value
$175,859,892
Price per share
$9.73
Number of holders
24
Value change
+$5,454,271
Number of buys
14
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 641288105?
CUSIP 641288105 identifies NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q3 2023

As of 30 Sep 2023, NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,073,997 shares. The largest 10 holders included KCK LTD., ORBIMED ADVISORS LLC, Soleus Capital Management, L.P., MORGAN STANLEY, Nantahala Capital Management, LLC, FMR LLC, Kent Lake Capital LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and EAM Investors, LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.